Federal Grand Jury Probe Reaches From the Capitol to the Dispensary

By CT CannaTimes Editorial Team

A sweeping federal investigation has cracked open what cannabis advocacy groups have warned for years: Connecticut’s cannabis licensing system, social equity rollout, and COVID-relief grant distribution may be riddled with fraud, insider deals, and political favoritism.

On July 31, 2025, The Hartford Courant revealed that a federal grand jury is investigating how tens of millions in government grants were distributed to Hartford-based nonprofits. But the probe is widening—federal agents are also examining Connecticut’s cannabis licensing program and the state’s broader handling of ARPA (American Rescue Plan Act) funds.

Subpoenas have already landed on the desk of State Senator Douglas McCrory, a powerful lawmaker tied to both cannabis policy and social services funding. His associate, Cicero Hamlin, a consultant with clients in the cannabis sector, is also named. According to The Courant, FBI agents are asking direct questions about the state’s expensive, highly competitive cannabis license process and the possible misuse of COVID-relief funds to advance private cannabis interests.

For years, whistleblowers and independent cannabis advocacy organizations have been calling attention to these very issues. The difference now? The Department of Justice is finally listening.

Timeline of Corruption: A Multi-Front Failure

2022–2024: Early Whistleblowers Raise Alarm

Multiple cannabis advocates and watchdogs began sounding alarms as early as 2022. Individuals who testified before legislative committees and submitted public reports detailed:

• Lack of transparency in license allocations

• Overreach and retaliation by the Department of Consumer Protection (DCP)

• Financial opacity within the Social Equity Council (SEC)

These were not isolated complaints. In March 2023, protestors rallied at the State Capitol to decry corporate domination of the cannabis market. “Why is it Curaleaf and not Jamaal from down the street?” one demonstrator asked. Another longtime advocate criticized the state for enabling out-of-state monopolies while dragging its feet on expungements and local business inclusion.

One anonymous activist noted the hypocrisy of the rollout: “People are still in prison for cannabis while others are making millions.” They called the state’s equity narrative “window dressing for political cover.”

Despite clear warnings, state leaders dismissed these concerns—until now, as the subpoenas begin to validate them.

2024–2025: ARPA Fraud Surfaces in Middletown

One of the most public examples of cannabis-linked financial misconduct occurred in Middletown, where a $2.5 million ARPA grant—intended to create a grocery store in a food desert—was quietly redirected toward a cannabis dispensary plan.

The would-be operator? Gerald “Jerry” Farrell Jr., former Commissioner of the Department of Consumer Protection. Farrell positioned himself to benefit personally from the ARPA-funded property.

Only after public scrutiny did city officials intervene. The dispensary proposal was ultimately withdrawn in June 2025. But the incident remains a glaring example of pandemic relief funds diverted to private, cannabis-related business by a politically connected ex-regulator.

Source: https://www.middletownpress.com/news/article/middletown-ct-cannabis-dispensary-arpa-grocery-ct-20312679.php

2024: Social Equity Council Implodes

Designed to empower communities harmed by the War on Drugs, the Social Equity Council (SEC) instead became a case study in dysfunction.

A 2024 audit by State Comptroller Sean Scanlon exposed:

• No strategic plan

• Conflicting or unclear applicant guidance

• Over $1 million in unnecessary consulting fees

• No-bid grants awarded with zero transparency

• Allegations that applicants were told to donate to churches or local groups to secure licenses

One particularly serious allegation centered on Ginne-Rae Clay, the former SEC director, who was accused of directing funds toward a church she personally attended. Clay resigned in July 2024 amid growing scrutiny.

Source: https://ctmirror.org/2024/07/17/ct-marijuana-social-equity-council-audit-report/

March 2025: Retaliation at DCP

In a deeply troubling incident, Rino Ferrarese, president of cannabis cultivator Affinity Grow, testified publicly against DCP’s testing regulations on March 20, 2025.

The very next day, DCP inspectors conducted a surprise raid on his facility. Though no violations were found and Commissioner Bryan Cafferelli issued a public apology, the agency refused to reveal who authorized the inspection.

Weeks later, DCP restructured internally and removed cannabis oversight from its Drug Control Division. No disciplinary action was made public. Accountability remains absent.

Sources: https://ctmirror.org/2025/03/28/ct-cannabis-dcp-affinity-grow-inspection-retaliation/ https://ctmirror.org/2025/04/12/ct-dcp-cannabis-regulation-affinity-grow-inspection/

2023–2025: Lab with Fraud History Licensed in Connecticut

Despite being named in a major fraud lawsuit in Massachusetts, Analytics Labs was licensed by Connecticut DCP as one of only two cannabis testing facilities in the state.

Filed in February 2025, the lawsuit alleges that Analytics Labs and others:

• Inflated THC potency numbers
• Falsified contaminant results
• Participated in lab shopping to attract growers

Even after Massachusetts regulators suspended one of the named labs, Analytics Labs continued operating in Connecticut. State officials have offered no explanation.

Sources: https://www.ctinsider.com/news/article/massachusetts-lab-sues-pot-competitors-ct-analytics-18698256.php https://www.registercitizen.com/news/article/connecticut-cannabis-lab-testing-analytics-labs-ct-17867824.php https://mjbizdaily.com/massachusetts-suspends-cannabis-testing-lab-over-contaminant-cover-up/

A Culture of Impunity

From ARPA fraud and license manipulation to retaliatory inspections and lab negligence, Connecticut’s cannabis system has become a playground for political insiders and unaccountable regulators.

Governor Lamont’s administration, the Department of Consumer Protection, the Social Equity Council, and legislative leaders all failed to act on early warnings. Only after federal subpoenas landed did the state quietly restructure agencies and shift responsibilities.

Equity was promised. Instead, cronyism and secrecy prevailed.

What Comes Next

As the grand jury probe unfolds, CT CannaTimes calls for immediate action:

• A public, independent inquiry into cannabis licensing and ARPA fund misuse
• A full report on DCP’s internal misconduct related to Affinity Grow
• Suspension of Analytics Labs pending resolution of all fraud allegations
• Enforceable transparency measures for all regulatory and advisory bodies

This isn’t just a cannabis story—it’s a story of systemic failure in Connecticut government. And the longer accountability is deferred, the deeper the public trust will erode.

We commend all whistleblowers—past and present—who raised their voices in the face of retaliation. Their warnings were ignored. But now, the record speaks for itself.

Source Links :

• https://www.courant.com/2025/07/31/federal-grand-jury-opens-probe-of-how-millions-in-grants-were-distributed-to-hartford-nonprofits/
• https://www.middletownpress.com/news/article/middletown-ct-cannabis-dispensary-arpa-grocery-ct-20312679.php
• https://ctsenaterepublicans.com/2025/03/republicans-seek-answers-on-pandemic-relief-funding/
• https://ctmirror.org/2024/07/17/ct-marijuana-social-equity-council-audit-report/
• https://ctmirror.org/2024/09/12/ct-marijuana-equity-social-equity-council-cannabis-licenses/
• https://ctmirror.org/2025/03/28/ct-cannabis-dcp-affinity-grow-inspection-retaliation/
• https://ctmirror.org/2025/04/12/ct-dcp-cannabis-regulation-affinity-grow-inspection/
• https://www.ctinsider.com/news/article/massachusetts-lab-sues-pot-competitors-ct-analytics-18698256.php
• https://www.registercitizen.com/news/article/connecticut-cannabis-lab-testing-analytics-labs-ct-17867824.php
• https://mjbizdaily.com/massachusetts-suspends-cannabis-testing-lab-over-contaminant-cover-up/